Aging & Elder Health Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging & Elder Health Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arthritis Therapy
Data from McGill University, University Health Center provide new insights into arthritis therapy
July 15th, 2007
Fresh data on arthritis are presented in the report "Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib. Celecoxib has a superior upper-gastrointestinal (GI) safety profile compared with nonselective nonsteroidal antiinflammatory drugs (NS-NSAIDs). It is unclear whether the utilization of a proton-pump inhibitor (PPI) with celecoxib confers additional protection in elderly patients," scientists in Montreal, Canada report. "We assessed the association between GI hospitalizations and use of celecoxib with a PPI versus celecoxib alone, and NS-NSAIDs with a PPI or NS-NSAIDs alone in elderly patients. We conducted a...
Source: Aging & Elder Health Week (2007-07-15)
|
